Let's Find Opportunities Overseas
Tag: InsiderBuying
 
    
  
  
  Teva Pharma: The Funds Believe. Should You?
Hedge fund legend Stanley Druckenmiller just upped his stake in TEVA by 65%—and he’s not alone. With 9 straight quarters of growth, rising biosimilar momentum, and a “Pivot to Growth” strategy in motion, Teva might finally be ready for its rerating. We still like the sandals, but the stock may be worth more than a hike.
 
    
  
  
  Insider Buy, Buffett Stamp, Swiss Roots: Is Chubb the Coolest Name in Insurance?
Wildfires can’t scorch this Swiss insurance juggernaut. With Buffett, big buys, and billion-dollar buybacks, Chubb may be the steadiest hot stock around. 🧯📈
Quick links
                      
                        Search
                      
                        Privacy Policy
                      
                        Refund Policy
                      
                        Shipping Policy
                      
                        Terms of Service
                      
                    
Contact us
About us
FUNanc!al distills the fun in finance and the finance in fun, makes news personal, and helps all reach happiness.
